Medication cost reduction in children on the ketogenic diet: data from a prospective study

J Child Neurol. 1999 Jul;14(7):469-71. doi: 10.1177/088307389901400712.

Abstract

In a prospective study of the efficacy of the ketogenic diet in children with severe, refractory epilepsy, data were collected on medication changes over 1 year. Cost reductions in medications were calculated over the first year and estimated for a second year. Fifty-seven percent of the children stayed on the diet for 1 year, and 74% of these children had their number of medications reduced. Forty-eight percent of children who stayed on the diet were on no medications at 12 months follow-up. Daily medication costs were reduced by nearly 70%.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / economics*
  • Anticonvulsants / therapeutic use
  • Child
  • Child, Preschool
  • Cost-Benefit Analysis
  • Dietary Fats / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Costs*
  • Epilepsy / diet therapy*
  • Epilepsy / drug therapy
  • Epilepsy / economics*
  • Female
  • Follow-Up Studies
  • Food-Drug Interactions
  • Humans
  • Infant
  • Ketosis* / etiology
  • Ketosis* / metabolism
  • Male
  • Patient Dropouts
  • Prospective Studies
  • Treatment Outcome

Substances

  • Anticonvulsants
  • Dietary Fats